• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO MISSION 3.0/18; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO MISSION 3.0/18; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 419122
Device Problem Structural Problem (2506)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/26/2020
Event Type  Injury  
Manufacturer Narrative
Combination product: yes.
 
Event Description
An orsiro mission drug-eluting stent system was selected for treatment of the lad.28 days post-procedure during a planned follow-up examination a malposition of the stent was detected.The patient presented no clinical symptoms.A target lesion revascularization was performed.Lot number and size is not available at this time.
 
Manufacturer Narrative
Combination product: yes.Lot number and device size added.28 days post-procedure during a planned follow-up examination a malposition of the stent was detected.During the scheduled intervention, a thrombus in the stent was detected with malposition of the stent struts.However, the clinical events committee adjudicated this event as a clinically driven tlr due to insufficient stent apposition with unlikely relationship to the device.The implanted stent could not be subjected to a technical investigation.However, the provided clinical information and the device production documentation were reviewed to establish whether a device deficiency and a deviation from the manufacturing process could be the cause for this event.Review of the product release documentation for the product described above confirmed that the device was manufactured according to specifications and fulfilled all the requirements of in-process and final inspection.Based on the reviewed documentation and the conducted investigation no device deficiency or manufacturing related root cause could be identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORSIRO MISSION 3.0/18
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BIOTRONIK AG, BUELACH, SWITZERLAND
ackerstrasse 6
buelach CH-81 80
CH  CH-8180
MDR Report Key11690682
MDR Text Key246223787
Report Number1028232-2021-01919
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
PMA/PMN Number
P170030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 04/19/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/19/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number419122
Device Catalogue NumberSEE MODEL NO.
Device Lot Number10195995
Was Device Available for Evaluation? No
Date Manufacturer Received08/05/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-